{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T11:13:26Z","timestamp":1784891606132,"version":"3.55.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004328","name":"Genentech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K23-EY022947"],"award-info":[{"award-number":["K23-EY022947"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007819","name":"Allergan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009857","name":"Regeneron Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004321","name":"Shire","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Retina"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.oret.2019.09.001","type":"journal-article","created":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T19:38:36Z","timestamp":1568144316000},"page":"154-163","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Longitudinal Panretinal Leakage and Ischemic Indices in Retinal Vascular Disease after Aflibercept Therapy"],"prefix":"10.1016","volume":"4","author":[{"given":"Natalia","family":"Figueiredo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil K.","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rishi P.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Babiuch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5769-0717","authenticated-orcid":false,"given":"Sumit","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5545-9474","authenticated-orcid":false,"given":"Aleksandra","family":"Rachitskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Talcott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Reese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0987-2916","authenticated-orcid":false,"given":"Ming","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6763-7768","authenticated-orcid":false,"given":"Justis P.","family":"Ehlers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.oret.2019.09.001_bib1","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.diabres.2011.10.029","article-title":"IDF Diabetes Atlas: global estimates of the prevalence of diabetes for 2011 and 2030","volume":"94","author":"Whiting","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.oret.2019.09.001_bib2","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0140-6736(09)62124-3","article-title":"Diabetic retinopathy","volume":"376","author":"Cheung","year":"2010","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.oret.2019.09.001_bib3","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S2213-8587(16)30052-3","article-title":"Diabetic macular oedema","volume":"5","author":"Tan","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"Suppl 1","key":"10.1016\/j.oret.2019.09.001_bib4","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1159\/000337157","article-title":"Anti-vascular endothelial growth factor treatment for retinal vein occlusions","volume":"227","author":"Campochiaro","year":"2012","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.oret.2019.09.001_bib5","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1016\/j.ophtha.2016.07.010","article-title":"Optical coherence tomography angiography of DME and its association with anti-VEGF treatment response","volume":"123","author":"Lee","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2019.09.001_bib6","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1056\/NEJMoa1414264","article-title":"Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema","volume":"372","author":"Wells","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.oret.2019.09.001_bib7","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1016\/j.ophtha.2014.05.006","article-title":"Intravitreal aflibercept for diabetic macular edema","volume":"121","author":"Korobelnik","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2019.09.001_bib8","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.ajo.2012.09.026","article-title":"Intravitreal aflibercept injection for macular edema secondary to central retinal vein occlusion: 1-year results from the phase 3 COPERNICUS study","volume":"155","author":"Brown","year":"2013","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2019.09.001_bib9","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.ajo.2014.07.027","article-title":"Intravitreal aflibercept for macular edema secondary to central retinal vein occlusion: 18-month results of the phase 3 GALILEO study","volume":"158","author":"Ogura","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2019.09.001_bib10","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ophtha.2015.09.035","article-title":"Intravitreal aflibercept for macular edema following branch retinal vein occlusion 52-week results of the VIBRANT Study","volume":"123","author":"Clark","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2019.09.001_bib11","first-page":"1","article-title":"Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathy","volume":"2015","author":"Virgili","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.oret.2019.09.001_bib12","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1136\/bjophthalmol-2011-300774","article-title":"Peripheral retinal ischaemia, as evaluated by ultra-widefield fluorescein angiography, is associated with diabetic macular oedema","volume":"96","author":"Wessel","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.oret.2019.09.001_bib13","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1097\/IAE.0000000000000148","article-title":"Area of peripheral retinal nonperfusion and treatment response in branch and central retinal vein occlusion","volume":"34","author":"Singer","year":"2014","journal-title":"Retina"},{"key":"10.1016\/j.oret.2019.09.001_bib14","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1097\/IAE.0b013e3182278b64","article-title":"Ultra\u2013wide-field angiography improves the detection and classification of diabetic retinopathy","volume":"32","author":"Wessel","year":"2012","journal-title":"Retina"},{"key":"10.1016\/j.oret.2019.09.001_bib15","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1136\/bjophthalmol-2016-310047","article-title":"Automated quantitative characterisation of retinal vascular leakage and microaneurysms in ultra-widefield fluorescein angiography","volume":"101","author":"Ehlers","year":"2017","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.oret.2019.09.001_bib16","doi-asserted-by":"crossref","first-page":"312","DOI":"10.3928\/23258160-20140709-07","article-title":"Precise montaging and metric quantification of retinal surface area from ultra-widefield fundus photography and fluorescein angiography","volume":"45","author":"Croft","year":"2014","journal-title":"Ophthalmic Surgery, Lasers Imaging Retin"},{"key":"10.1016\/j.oret.2019.09.001_bib17","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ajo.2014.03.009","article-title":"Patterns of peripheral retinal and central macula ischemia in diabetic retinopathy as evaluated by ultra-widefield fluorescein angiography","volume":"158","author":"Sim","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2019.09.001_bib18","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/IAE.0b013e3181e36c6d","article-title":"Ischemic index and neovascularization in central retinal vein occlusion","volume":"31","author":"Tsui","year":"2011","journal-title":"Retina"},{"key":"10.1016\/j.oret.2019.09.001_bib19","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1016\/j.ophtha.2015.07.034","article-title":"Diabetic retinopathy severity and peripheral lesions are associated with nonperfusion on ultrawide field angiography","volume":"122","author":"Silva","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2019.09.001_bib20","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ajo.2017.05.024","article-title":"Distribution of nonperfusion area on ultra-widefield fluorescein angiography in eyes with diabetic macular edema: DAVE Study","volume":"180","author":"Fan","year":"2017","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2019.09.001_bib21","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1167\/tvst.6.2.7","article-title":"A\u00a0quantitative approach to predict differential effects of anti-VEGF treatment on diffuse and focal leakage in patients with diabetic macular edema: a pilot study","volume":"6","author":"Allingham","year":"2017","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.oret.2019.09.001_bib22","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.ajo.2013.01.007","article-title":"Characterization of ischemic index using ultra-widefield fluorescein angiography in patients with focal and diffuse recalcitrant diabetic macular edema","volume":"155","author":"Patel","year":"2013","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2019.09.001_bib23","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1136\/bjophthalmol-2017-311475","article-title":"Changes in retinal ischaemic index correlate with recalcitrant macular oedema in retinal vein occlusion: WAVE study","volume":"102","author":"Kwon","year":"2019","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.oret.2019.09.001_bib24","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/j.ophtha.2014.03.021","article-title":"Neutralization of vascular endothelial growth factor slows progression of retinal nonperfusion in patients with diabetic macular edema","volume":"121","author":"Campochiaro","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2019.09.001_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajo.2019.03.030","article-title":"Classification of regions of nonperfusion on ultra-widefield fluorescein angiography in patients with diabetic macular edema","author":"Fang","year":"2019","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2019.09.001_bib26","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.ophtha.2012.09.032","article-title":"Vascular endothelial growth factor promotes progressive retinal nonperfusion in patients with retinal vein occlusion","volume":"120","author":"Campochiaro","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2019.09.001_bib27","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3928\/23258160-20180329-08","article-title":"Longitudinal quantification of retinal nonperfusion in the macula of eyes with retinal vein occlusion receiving anti-VEGF therapy: secondary analysis of the WAVE randomized trial","volume":"49","author":"Ou","year":"2018","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"10.1016\/j.oret.2019.09.001_bib28","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.ophtha.2015.10.030","article-title":"Changes in retinal nonperfusion associated with suppression of vascular endothelial growth factor in retinal vein occlusion","volume":"123","author":"Mir","year":"2016","journal-title":"Ophthalmology"}],"container-title":["Ophthalmology Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653019305391?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653019305391?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T09:27:12Z","timestamp":1762853232000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468653019305391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S2468653019305391"],"URL":"https:\/\/doi.org\/10.1016\/j.oret.2019.09.001","relation":{},"ISSN":["2468-6530"],"issn-type":[{"value":"2468-6530","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Longitudinal Panretinal Leakage and Ischemic Indices in Retinal Vascular Disease after Aflibercept Therapy","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Retina","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oret.2019.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}